newsfilter
← Latest News
GlobeNewswire·

Kuros Biosciences’s licensee Checkmate Pharmaceuticals completes its IPO on NASDAQ

Total gross proceeds raised by Checkmate in IPO of $86.25 million (including sale of overallotment shares)Intention to use part of the net proceeds from the IPO to fund the development of its product...